| COVID 19 hospitalized | ||||
| COVID 19 hospitalized | COVID 19 all comers | COVID-19 mild to moderate | COVID-19 severe or critically | |
| neutralizing antibody | ITAC | |||
| amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) | ACTIV-3 ... | |||
| bamlanivimab monotherapy | ACTIV-3/TICO LY-CoV555 | |||
| casirivimab/imdevimab (Ronapreve) | RECOVERY ... | Somersan-Karakaya ... Suzuki | ||
| cilgavimab and tixagevimab (Evusheld) | ACTIV-3/TICO ... | Chen | ||
| equine polyclonal antibodies INM005 | Lopardo | |||
| sotrovimab (Xevudy; VIR-7831) | ACTIV-3/ TICO ... | |||
| 5570 | CT-P59 1.2, 2020 | 2 | 1 | 0 | excluded | risk of bias not avaialble |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
